Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma von Maráz, Anikó, Cserháti, Adrienn, Uhercsák, Gabriella, Szilágyi, Éva, Varga, Zoltán, Révész, János, Kószó, Renáta, Varga, Linda, Kahán, Zsuzsanna

Volltext

Full Body Surface Coverage with Water-Equivalent Bolus as Novel Technique for Total Body Irradiation before Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoid Leuk... von Furka, Andrea, Nagy, Zsofia, Szabó, Imre, Fekete, Gábor, Kelemen, Ágnes, Bolobás, Gábor, Sebők, Gábriel, Molnár, Tünde, Árvai, János, Tornyi, Ilona, Kostyál, László, Révész, János, Hauser, Peter

Volltext

Treatment Algorithm for Cancerous Wounds: A Systematic Review von Furka, Andrea, Simkó, Csaba, Kostyál, László, Szabó, Imre, Valikovics, Anikó, Fekete, Gábor, Tornyi, Ilona, Oross, Endre, Révész, János

Volltext

Assessment of the Role of Everolimus Therapy in Patients with Renal Cell Carcinoma Based on Daily Routine and Recent Research Results von Maráz, Anikó, Csejtei, András, Kocsis, Judit, Szűcs, Miklós, Kahán, Zsuzsanna, Bodoky, György, Dank, Magdolna, Mangel, László, Révész, János, Varga, Zoltán, Géczi, Lajos

Volltext

The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract von Pósfai, Boglárka, Kuthi, Levente, Varga, Linda, Laczó, Ibolya, Révész, János, Kránicz, Réka, Maráz, Anikó

Volltext

Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data von Revesz, Janos, Posfai, Boglarka, Pajor, Laszlo, Papdan, Timea, Varga, Linda, Paczona, Viktor R, Varga, Zoltan, Sukosd, Farkas, Maraz, Aniko

Volltext

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma von Rini, Brian I, Plimack, Elizabeth R, Stus, Viktor, Gafanov, Rustem, Hawkins, Robert, Nosov, Dmitry, Pouliot, Frédéric, Alekseev, Boris, Soulières, Denis, Melichar, Bohuslav, Vynnychenko, Ihor, Kryzhanivska, Anna, Bondarenko, Igor, Azevedo, Sergio J, Borchiellini, Delphine, Szczylik, Cezary, Markus, Maurice, McDermott, Raymond S, Bedke, Jens, Tartas, Sophie, Chang, Yen-Hwa, Tamada, Satoshi, Shou, Qiong, Perini, Rodolfo F, Chen, Mei, Atkins, Michael B, Powles, Thomas

Volltext

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial von Powles, Thomas, Oudard, Stephane, Vulsteke, Christof, Fléchon, Aude, Yu, Evan Y, Imai, Kentaro, Homet Moreno, Blanca, Alva, Ajjai, Lazzaro, Mauricio Fernandez, Gatica, Gabriela, Van Aelst, Filip, Machiels, Jean-Pascal, Schallier, Denis, Brust, Leandro, Soares, Joao Paulo Holanda, Cheng, Susanna, Leal, Jose Luis, Ibanez, Carolina, Laguerre, Brigitte, Flechon, Aude, Topart, Delphine, Huillard, Olivier, Gravis, Gwenaelle, Reichardt, Peter, Herden, Jan, Pfister, David, Niegisch, Guenter, Boegemann, Martin, Gakis, Georgios, Neisius, Andreas, Thomas, Christian, Kosa, Judit Erzsebet, Bodoky, Gyorgy, Geczi, Lajos, Frank, Stephen Jay, Kejzman, Daniel, Rosenbaum, Eli, Rouvinov, Keren, Arai, Gaku, Takayama, Tatsuya, Fujimoto, Kiyohide, Tanikawa, Toshiki, Tomita, Yoshihiko, Nishimura, Kazuo, Tsujihata, Masao, Takano, Toshimi, Joraku, Akira, Kobayashi, Kazuki, De Wit, Ronald, Aarts, Maureen, Beerepoot, Laurens, Alekseev, Sergey M, Zyryanov, Alexander, Oschepkov, Vasiliy Nikolaevich, Shidin, Vladimir Aleksandrovich, Karlov, Petr Alexandrovich, Cohen, Graham Lawrence, Ruff, Paul, Lee, Nari, Rodriguez-Vida, Alejo, Grande, Enrique, Munoz Langa, Jose, Montesa Pino, Alvaro, Su, Wen-Pin, Chang, Yen-Hwa, Huang, Yi-Hsiu, Srimuninnimit, Vichien, Abali, Huseyin, Sendur, Mehmet Ali Nahit, Ozguroglu, Mustafa, Ozdogan, Mustafa, Evans, Linda, Hussain, Syed, DiSimone, Christopher, Schlegel, Peter, Mamtani, Ronac, Wallace, James, Suh, Jason Jung-Gon, Burgess, Earle, Wong, John, Chaudhry, Arvind, Thomas, Christian A, Fitzharris, John T, Oliff, Ira A, Vuky, Jacqueline, Hauke, Ralph, Joshi, Monika, Bolemon, Britt H, Markus, Maurice, Pfanzelter, Nicklas, Lawler, William Eyre, Courtright, Jay G, Doshi, Gurjyot, Sartor, Oliver Alton, Mannuel, Heather D, Alva, Ajjai, Charles, Anthony, Ades, Steven, Yu, Evan, Fleming, Mark

Volltext

Correlation between FGFR mutation and PD-L1 expression of urinary bladder cancers: A real-world based biomarker study von Maraz, Aniko, Takacs, Peter, Lawson, Joe, Santiago-Walker, Ademi, Pajor, Laszlo, Sukosd, Farkas, Revesz, Janos

Volltext

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) von Schneeweiss, A., Puglisi, F., Peretz-Yablonski, T., Merot, J.-L., Miles, D., Coudert, Bruno, Errihani, Hassan, Dalenc, Florence, Barrett, Sophie, Beato, Carlos, Hu, Xichun, Perrin, Christophe, Ettl, Johannes, Li, Huiping, Cariello, Anna, Frassoldati, Antonio, Wronski, Andrzej, Menjón Beltrán, Salomón, Cicin, Irfan, Schmid, Peter, Juarez, Alejandro, Matos, Erika, Uslu, Ruchan, Wildiers, Hans, Bourgeois, Hugues, von Schumann, Raquel, Wojtukiewicz, Marek, Peron, Yann Izarzugaza, Wheatley, Duncan, De Boer, Richard, Jerusalem, Guy, Latini, Luciano, Barnadas Molins, Agusti, Martinez, Eduardo, Baird, Richard, McCarthy, Nicole, Greil, Richard, Juhasz-Boess, Ingolf, de la Cruz, Luis Ruiz, Del Val, Olga, Azribi, Fathi, Turner, Nicholas, Andrade, Jurandyr, Bernstein, Vanessa, Rayson, Daniel, Gennari, Alessandra, El-Saghir, Nagi, Kukulska, Monika, Pelaez, Ignacio, del Mar Gordon, Maria, Varughese, Mohini, Levitt, Nicola, Singer, Christian, Efremidou, Anna, Evron, Ella, Luigi, Cavanna, Garcia, Andres, Lopez Ceballos, Maria Helena, García, María, Arcediano, Alberto, McAdam, Karen, Humphreys, Alison, de Grève, Jacques, Joy, Anil, Sehdev, Sandeep, Kütner, Riina, Laplaige, Philippe, Christensen, Bernd, Fountzilas, Georgios, Fried, Georgeta, Giacobino, Alice, Bonetti, Andrea, Van der Velden, Annette, Vrijaldenhoven, Suzan, Andres Conejero, Raquel, Murias, Adolfo, Saura, Salvador, Poole, Christopher, Woodward, Natasha, Califaretti, Nadia, Jiang, Jun, Padrik, Peeter, Saarni, Outi, Genet, Dominique, Catala, Stéphanie, Facchini, Thomas, Repp, Roland, Schroeder, Willibald, Kahan, Zsuzsanna, Rosengarten, Ora, Alabiso, Oscar, Van de Wouw, Yes, Sousa, Gabriela, Jesús Florián Jerico, Marta Santisteban, Torrego, Juan Carlos, Rodriguez, Cesar, Llorca, Cristina, Galán, Antonio, Rodríguez, Robinson, Alonso, Isabel

Volltext

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma von Choueiri, Toni K., Powles, Thomas, Peltola, Katriina, de Velasco, Guillermo, Burotto, Mauricio, Suarez, Cristina, Ghatalia, Pooja, Iacovelli, Roberto, Lam, Elaine T., Verzoni, Elena, Gümüş, Mahmut, Stadler, Walter M., Kollmannsberger, Christian, Melichar, Bohuslav, Venugopal, Balaji, Gross-Goupil, Marine, Poprach, Alexandr, De Santis, Maria, Schutz, Fabio A., Park, Se Hoon, Nosov, Dmitry A., Porta, Camillo, Lee, Jae Lyun, Garcia-del-Muro, Xavier, Biscaldi, Elisa, Manneh Kopp, Ray, Oya, Mototsugu, He, Li, Wang, Aobo, Perini, Rodolfo F., Vickery, Donna, Albiges, Laurence, Rini, Brian

Volltext

Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer von Powles, Thomas, Gschwend, Juergen E., Loriot, Yohann, Bellmunt, Joaquim, Geczi, Lajos, Vulsteke, Christof, Abdelsalam, Mahmoud, Gafanov, Rustem, Bae, Woo Kyun, Revesz, Janos, Yamamoto, Yoshiaki, Anido, Urbano, Su, Wen-Pin, Fleming, Mark T., Markus, Maurice, Feng, Dai, Poehlein, Christian Heinrich, Alva, Ajjai

Volltext

Guidelines on Audit Quality von Mazur, Jacek, Révész, János, Vella, Brian, Havens, Harry

Volltext

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) von Bachelot, T, Ciruelos, E, Schneeweiss, A, Puglisi, F, Peretz-Yablonski, T, Bondarenko, I, Paluch-Shimon, S, Wardley, A, Merot, J-L, du Toit, Y, Easton, V, Lindegger, N, Miles, D

Volltext

Zempléni Árpád, Takács Ilus, Révész János, Riszdorfer Imre, Szokol Irén, Beyer – Móricz Zsigmond (1912-05-19) von Zempléni Árpád, Takács Ilus, Révész János, Riszdorfer Imre, Szokol Irén, Beyer, János RévR, Imer Riszdorfer

Volltext bestellen

Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20 von Weiszhár, Zsóka, Czúcz, Judit, Révész, Csaba, Rosivall, László, Szebeni, János, Rozsnyay, Zoltán

Volltext

Spiral-Shaped Piezoelectric MEMS Cantilever Array for Fully Implantable Hearing Systems von Udvardi, Péter, Radó, János, Straszner, András, Ferencz, János, Hajnal, Zoltán, Soleimani, Saeedeh, Schneider, Michael, Schmid, Ulrich, Révész, Péter, Volk, János

Volltext

A comparative study of femtosecond pulsed laser ablation of meloxicam in distilled water and in air von Nagy, Eszter, Kopniczky, Judit, Smausz, Tamás, Náfrádi, Máté, Alapi, Tünde, Bohus, János, Pajer, Viktor, Szabó-Révész, Piroska, Ambrus, Rita, Hopp, Béla

Volltext

Eternal Questions of Gifted Education from the Aspect of University Teachers von RÉVÉSZ, György, SZABÓ, János

Volltext

The most important attributes for talented students who want to be scientists von Szabó, János, Révész, Habil György, Van-Dyke, David J

Volltext